Crossmark

EGFR tyrosine kinase inhibitor: design, synthesis, characterization, biological evaluation, and molecular docking of novel 1,3,4-oxadiazole, thio-methyl, and 1,2,3-triazole hybrids

Crossref DOI link: https://doi.org/10.1007/s44442-025-00004-2

Published Online: 2025-07-08

Published Print: 2025-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Alshamari, Asma Khalaf

AlRashidi, Aljazi Abdullah

Abdella, Faiza I. A.

Alshammari, Hissah Khashman

Alshammari, Mona Zaheed

Alsaif, Nuha Othman S.

Malah, Tamer El https://orcid.org/0000-0002-2868-3857
Funding

Funding for this research was provided by:

University of Hail (RG-24 085)
License Information

Text and Data Mining valid from 2025-07-01

Version of Record valid from 2025-07-08
More Information

Article History

Received: 24 January 2025

Accepted: 10 April 2025

First Online: 8 July 2025

Declarations

:

: The authors declare that no conflicts of interests.

Document is current

Any future updates will be listed below